Abiopharma

🔍 Kennard William E (Director)

Company: METLIFE INC (MET)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 721 shares of Common Stock at $71.17 per share (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 46,501.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: H | nature_of_ownership: By the MetLife Policyholder Trust | shares_owned_after: 10.00 | Footnotes: F2

Footnotes:

• F1: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.
• F2: Shares held in trust under the MetLife Policyholder Trust established to hold shares of common stock allocated to eligible policyholders of Metropolitan Life Insurance Company, a wholly-owned subsidiary of MetLife, Inc.